| Literature DB >> 28800106 |
Abstract
The past decade has seen an increasing number of extensive studies devoted to the exploitation of ordered mesoporous carbon (OMC) materials in electrochemistry, notably in the fields of energy and sensing. The present review summarizes the recent achievements made in field of electroanalysis using electrodes modified with such nanomaterials. On the basis of comprehensive tables, the interest in OMC for designing electrochemical sensors is illustrated through the various applications developed to date. They include voltammetric detection after preconcentration, electrocatalysis (intrinsically due to OMC or based on suitable catalysts deposited onto OMC), electrochemical biosensors, as well as electrochemiluminescence and potentiometric sensors.Entities:
Keywords: carbon composite; carbon nanomaterials; electrocatalysis; electrochemical biosensors; electrochemical sensors; functionalization; modified electrodes; ordered mesoporous carbon; preconcentration; template
Year: 2017 PMID: 28800106 PMCID: PMC5579580 DOI: 10.3390/s17081863
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Illustration of the hard template casting route to OMC: (A) Hexagonal CMK-3; (B) Cubic CMK-1.
Figure 2Schematic description of the soft template route to OMC using resorcinol-formaldehyde as carbon source and F127 as copolymer template (adapted from [37]).
Figure 3(A,B,D) TEM micrographs and (C,E) XRD diffractograms of (A–C) hexagonal CMK-3 and (D,E) cubic CMK-1 materials. TEM views of CMK-3 show both the hexagonal packing (A) and the long mesopores (B), while XRD data include also the diffractograms corresponding to the mother SBA-15 (C) and MCM-48 (E) mesoporous silica templates. (F) Pore size distributions for CMK-3 and CMK-1. Data have been reproduced/adapted from [38] (A,B), [40] (C), [39] (D), [16] (E), and [33,41] (F).
Figure 4(A) Cyclic voltammograms of an OMC (COU-3 type) film electrode at various scan rates (reproduced from [42]). (B) Cyclic voltammograms of 1 mM [Fe(CN)6]3−/[Fe(CN)6]4− in 0.1 M KCl recorded at 75 mV∙s−1 using screen-printed carbon electrodes (SPCE): (a–c) blank, bare SPCE, and CMK-3/chitosan modified SPCE (reproduced from [43]). (C) Cyclic voltammograms of xanthine recorded at bare glassy carbon electrode (GCE) and graphitized mesoporous carbon (GMC) modified GCE (reproduced from [44]). (D) Cyclic voltammograms on different carbon electrodes recorded in 3 M H2SO4 and 1 M VOSO4 at 50 mV∙s−1 (reproduced from [48]).
Electrochemical sensors based on electrodes prepared from templated ordered porous carbon materials (unmodified).
| Analyte a | Type of Porous Materials b | Electrode Configuration c | Detection Method | Analytical Performance | Reference | |||
|---|---|---|---|---|---|---|---|---|
| Procedure d | Technique e | Concentration Range | Det. Limit | |||||
| Ascorbic acid | CMK-1 (KIT-6/PF resin) | GCE/(OMC + Nafion) film | Direct det./EC | DPV | 4 × 10−5–8 × 10−4 M | 2 × 10−5 M | [ | |
| Ascorbic acid | Mesoporous carbon nanofiber | PGE/OMC film | Direct det./EC | DPV | 1 × 10−4–1 × 10−2 M | 5 × 10−5 M | [ | |
| Ascorbic acid | Mesoporous carbon nanofiber | GCE/OMC film | Direct det./EC | A | 2 × 10−8–2.25 × 10−3 M | 1.6 × 10−8 M | [ | |
| Ascorbic acid | CMK-3 (SBA-15/Furfuryl alcohol) | GCE/OMC film | Direct det./EC | DPV | 8 × 10−5–1.4 × 10−3 M | 1.4 × 10−5 M | [ | |
| Bisphenol A | CMK-3 (SBA-15/sucrose) | IL-CPE + OMC | Acc. (3 min)—det. | LSV | 2 × 10−7–1.5 × 10−4 M | 5 × 10−8 M | [ | |
| Calcium dobesilate | CMK-3 (SBA-15/sucrose) | PGE/OMC film | Direct det./EC | CV | 1 × 10−7–1.3 × 10−3 M | 4.0 × 10−8 M | [ | |
| Capsaicin | Mesoporous cellular foam | CPE + OMC | Acc. (1 min)—det. | DPV | 7.6 × 10−7–1.16 × 10−5 M | 8 × 10−8 M | [ | |
| Carbendazim | CMK-3 (SBA-15/sucrose) | IL-CPE + OMC | Acc. (3 min)—det. | DPV | 1.25–800 µg/L | 0.5 µg/L | [ | |
| Carvedilol | CMK-1 (MCM-48/sucrose) | GCE/OMC film | Direct det. | DPV | 1 × 10−7–2.3 × 10−5 M | 3.4 × 10−8 M | [ | |
| Catechol | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Acc. (4 min)—det. | LSV | 5 × 10−7–3.5 × 10−5 M | 1 × 10−7 M | [ | |
| Catechol | Mesoporous carbon | GCE/(OMC + IL) film | Direct det. | DPV | 1 × 10−7–5 × 10−5 M | 6 × 10−8 M | [ | |
| Chloramphenicol | CMK-1 (KIT-6/PF resin) | GCE/OMC/Nafion film | Acc. (4 min)—det. | LSV | 5.0 × 10−7–6.0 × 10−5 M | 8.5 × 10−9 M | [ | |
| Chlorogenic acid | DMC (nanosilica/sucrose) | IL-CPE + OMC | Acc. (2 min)—det. | SWV | 2 × 10−8–2.5 × 10−6 M | 1 × 10−8 M | [ | |
| CdII | Mesoporous graphene framework | GCE/(MGF + Nafion) film | Acc. (6 min at −1.2 V)—det. | DPASV | 2–70 µg/L | 0.5 µg/L | [ | |
| CuII | CMK-3 (SBA-15/sucrose) | GCE/(OMC + PANI) film | Acc. (2.5 min)—det. | ASV | 1 × 10−8–1 × 10−6 M | 6 × 10−9 M | [ | |
| CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | CV | 1.8 × 10−6–2.5 × 10−3 M | 2.0 × 10−9 M | [ | ||
| CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | A | 3 × 10−6–1.3 × 10−4 M | 1 × 10−8 M | [ | ||
| DNA bases | purine(G,A) | Mesoporous carbon fibers | GCE/(MCFs + chitosan) film | Direct det./EC | DPV | 2.5 × 10−6–2.0 × 10−5 M | 4.8 × 10−7 M | [ |
| pyrimidine (T,C) | ||||||||
| Dopamine | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | CV | 4 × 10−5–1 × 10−3 M | - | [ | |
| Epinephrine | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | A | 1 × 10−7–1.2 × 10−3 M | 3.5 × 10−8 M | [ | |
| Epinephrine | Mesoporous carbon foam | GCE/(MCF + Salep) film | Direct det./EC | DPV | 1 × 10−7–1.2 × 10−6 M | 4.0 × 10−8 M | [ | |
| Estrogens | CMK-3 (SBA-15/sucrose) | GPE/(OMC + graphene) film | Acc. (4 min)—det. | SWV | 5.0 × 10−9–2.0 × 10−6 M | 2.0 × 10−9 M | [ | |
| Folic acid | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Acc. (10 s)—det. | LSV | 5.0 × 10−10–1.0 × 10−7 M | 6.0 × 10−11 M | [ | |
| Glucose | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | A | 5 × 10−4–5 × 10−3 M | 2 × 10−5 M | [ | |
| Hydroquinone | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | DPV | 1.0 × 10−7–5.0 × 10−3 M | 3.14 × 10−8 M | [ | |
| Hydroquinone | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | A | 1 × 10−5–2 × 10−4 M | 7.6 × 10−8 M | [ | |
| Isoniazid | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | A | 1.0 × 10−7–3.7 × 10−4 M | 8.4 × 10−8 M | [ | |
| Melamine | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | DPV | 5 × 10−8–7 × 10−6 M | 2.4 × 10−9 M | [ | |
| Methyl parathion | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Acc. (5 min)—det. | LSV | 9 × 10−8–6.1 × 10−5 M | 7.6 × 10−9 M | [ | |
| Morphine | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Acc. (5 min)—det. | CV | 1 × 10−7–2 × 10−5 M | 1 × 10−8 M | [ | |
| Morphine | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | A | 2 × 10−7–1.98 × 10−4 M | 3 × 10−8 M | [ | |
| NADH | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | A | 5 × 10−6–9 × 10−4 M | 1.6 × 10−6 M | [ | |
| NADH | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | A | 2 × 10−6–1.1 × 10−3 M | 1.0 × 10−6 M | [ | |
| NADH | CMK-1 (KIT-6/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | A | 3.0 × 10−6–1.4 × 10−3 M | 1.0 × 10−6 M | [ | |
| Nitrite | HONC (SBA-15/Furfuryl alcohol) | GCE/OMC film | Acc. (2 min)—det. | DPV | 7.0 × 10−6–1.6 × 10−3 M | - | [ | |
| Nitroaromatic (TNT) | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Acc. (2 min)—det. | AdsSV | 1–50 ppb | 0.2 ppb | [ | |
| Nitroaromatic (TNT, TNB, DNT, DNB) | CMK-3 (SBA-15/sucrose) | CDE/OMC/Nafion film | Direct det./EC | CE-A | 8.4–5.0 µg/L | 3–4.7 µg/L | [ | |
| Nitrobenzene | Bi-modal MMPCM | GCE/OMC film | Acc.—det. | LSV | 2 × 10−7–4 × 10−5 M | 8 × 10−9 M | [ | |
| Nitrophenols | o-NP | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Direct det./EC | DPV | 5 × 10−7–1.0 × 10−4 M | 8 × 10−8 M | [ |
| m-NP | ||||||||
| p-NP | ||||||||
| Nitroxoline | CMK-3 (SBA-15/sucrose) | CPE + OMC | Acc. (4 min)—det. | SW-AdsSV | 1.0 × 10−11–1.0 × 10−7 M | 3.0 × 10−12 M | [ | |
| Paraoxon | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Acc. (6 min at −0.6 V)—det. | DPV | 1.0 × 10−8–2.0 × 10−5 M | 1.9 × 10−9 M | [ | |
| PbII | CMK-3 (SBA-15/sucrose) | GCE/(OMC + Nafion) film | Acc. (5 min)—det. | ASDPV | 2 × 10−8–2 × 10−6 M | 4.6 × 10−9 M | [ | |
| PbII | CMK-3 (SBA-15/sucrose) | CILE/(OMC + ENIM-BF4 + chitosan) film | Acc. (200 s)—det. | ASDPV | 5 × 10−8–1.4 × 10−6 M | 2.5 × 10−8 M | [ | |
| Poly-phenols | 1,4-DHB | Graphitized mesoporous carbon | GCE/OMC film | Direct det. | DPV | 4.0 × 10−5–2.5 × 10−4 M | 9.1 × 10−7 M | [ |
| 1,2-DHB | ||||||||
| 1,3-DHB | ||||||||
| Prednisolone | OMC | GCE/OMC film | Direct det./EC | SWV | 6 × 10−8–4.0 × 10−5 M | 5.7 × 10−8 M | [ | |
| Ractopamine | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | DPV | 8.5 × 10−8–8.0 × 10−6 M | 6 × 10−8 M | [ | |
| Riboflavin | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Acc.—det. | CV | 4.0 × 10−7–1.0 × 10−6 M | 2 × 10−8 M | [ | |
| Rutin | DMC | IL-CPE + OMC | Acc. (7 min)—det. | SWV | 8 × 10−9–4.0 × 10−6 M | 1.17 × 10−9 M | [ | |
| Sudan I | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Acc.—det. | ASDPV | 4.0 × 10−7–6.6 × 10−5 M | 2.44 × 10−9 M | [ | |
| Tirapazamine | CMK-3 (SBA-15/sucrose) | PGE/OMC film | Acc.—det. | DPV | 5 × 10−11–1.5 × 10−5 M | 2.0 × 10−11 M | [ | |
| Triclosan | CMK-3 (SBA-15/sucrose) | SPCE/(OMC + chitosan) film | Direct det. | SWV | 0.8–40 µg/L | 0.24 µg/L | [ | |
| CMK-3 (SBA-15/Furfuryl alcohol) | GCE/OMC film | Direct det./EC | DPV | 1.5 × 10−5–9 × 10−4 M | 1.0 × 10−5 M | [ | ||
| Uric acid | CMK-3 (SBA-15/sucrose) | GCE/OMC film | Direct det./EC | CV | 7 × 10−6–1.5 × 10−4 M | 2.0 × 10−6 M | [ | |
| Uric acid | CMK-3 (SBA-15/sucrose) | PGE/OMC film | Direct det./EC | A | 1.0 × 10−6–1.0 × 10−4 M | 4.0 × 10−7 M | [ | |
| Xanthine | Graphitized mesoporous carbon | GCE/OMC film | Direct det./EC | DPV | 2 × 10−5–2.4 × 10−4 M | 3.51 × 10−7 M | [ | |
a Abbreviations: NADH, nicotinamide adenine dinucleotide (reduced form); TNT, 2,4,6-trinitrotuluene; TNB, 1,3,5-trinitrobenzene; DNT, 2,4-dinitrotuluene; DNB, 1,3-dinitrobenzene; NP, nitrophenol; DHB, dihydroxy benzene; DNA (deoxyribonucleic acid) bases (A, adenine; G, guanine; C,cytosine; T, thymine). b Abbreviations: CMK, carbon mesostructures at KAIST; KIT, Korean Institute of Technology; PF resin, phenol formaldehyde resin; SBA, Santa Barbara Amorphous; MCM, Mobil Composition of Matter; BMIMPF6, ionic liquid of 1-octyl-3-methylimidazolium bromide; DMC, highly defective mesoporous carbon; HONC, hemi-ordered nanoporous carbon; MMPCM, micro-/meso-porous carbon material. c Abbreviations: GCE, glassy carbon electrode; OMC, ordered mesoporous carbon (general term to name the porous carbon material, even if modified, as detailed in the preceeding column); PGE, pyrolytic graphite electrode; IL, ionic liquid; CPE, carbon paste electrode; MGF, mesoporous graphene framework; PANI, polyaniline; MCF+Salep, mesoporous carbon foam dispersed in Salep; GPE, graphite paste electrode; CDE, carbon disk electrode; CILE, carbon ionic liquid electrode; ENIM-BF4, 1-ethyl-3-methylimidazolium tetrafluoroborate ionic liquid; MCFs, mesoporous carbon fibers; SPCE, scree-printed carbon electrode. d Abbreviations: det., detection; EC, electrocatalysis; acc., accumulation. e Abbreviations: DPV, differential pulse voltammetry; A, amperometry; LSV, linear sweep voltammetry; CV, cyclic voltammetry; SWV, square wave voltammetry; DPASV, differential pulse anodic stripping voltammetry; ASV, anodic stripping voltammetry; AdsSV, adsorptive stripping voltammetry; CE-A, capillary electrophoresis with amperometric detection; SW-AdsSV, square wave adsorptive stripping voltammetry; ASDPV, anodic stripping differential pulse voltammetry.
Figure 5(A) Cyclic voltammograms of glassy carbon electrodes (GCE) modified with mesoporous carbon nanospheres (MCNS), non-porous carbon spheres (CS), and mesoporous silica nanospheres (MSNS) in 0.1 M pH 7.4 PBS containing 0.4 mM ascorbic acid (AA), 4 µM dopamine (DA) and 30 µM uric acid (UA). (B) Cyclic voltammograms of GCE modified with MCNS, graphene (GR), and carbon nanotubes (CNT) in 0.1 M pH 7.4 PBS containing 0.4 mM AA, 4 µM DA and 30 µM UA (reproduced from [104]).
Figure 6Illustration of the various ways to functionalizing OMC used in electrochemical sensors: (A) surface oxidation and grafting; (B) bulk N,S-doping; (C) adsorption of mediators (D) binding of metal nanoparticles or deposition of metal, metal oxide or metal sulfide; (E) electropolymerization.
Electrochemical sensors based on electrodes prepared from functionalized templated ordered porous carbon materials.
| Analyte a | Porous Materials | Electrode Configuration d | Detection Method | Analytical Performance | Reference | |||
|---|---|---|---|---|---|---|---|---|
| Type b | Modifier c | Procedure e | Technique f | Concentration Range | Det. Limit | |||
| Acetylcholine | CMK-3 (SBA-15/sucrose) | Ni-Al LDH | GCE/OMC/LDH film | Mediated EC | A | 2 × 10−6–4.92 × 10−3 M | 4.2 × 10−8 M | [ |
| Ag+ | Macroporous carbon | Ag+ ionophores | OMC/membrane | Direct det. | P | 10−10–10−11 M | 3.8 × 10−11 M | [ |
| Ascorbic acid | CMK-3 (SBA-15/sucrose) | Ferrocene-COOH | GCE/(OMC + Nafion) film | Mediated EC | A | 5 × 10−5–3.5 × 10−4 M | 9 × 10−6 M | [ |
| Ascorbic acid | N-PCNPs (ZIF-8/Zn(Ac)2/methylimidazole) | N (nitrogen) | GCE/OMC film | Supported EC | DPV | 8 × 10−5–2 × 10−3 M | 7.4 × 10−7 M | [ |
| Ascorbic acid | N-doped OMC (SBA-15/poly(ethylenediamine)) | N (nitrogen) | GCE/(OMC + Nafion) film | Direct det./EC | SWV | 1 × 10−6–7 × 10−4 M | 1 × 10−8 M | [ |
| Ascorbic acid | N-doped OMC (3-amino phenol/formaldehyde resin) | N (nitrogen) | GCE/OMC film | Direct det./EC | SWV | 1.0 × 10−6–1.2 × 10−4 M | 1.0 × 10−7 M | [ |
| 6-Benzylaminopurine | CMK-3 (SBA-15/sucrose) | Platinum NPs | GCE/(OMC + Nafion) film | Supported EC | A | 5 × 10−8–2.4 × 10−5 M | 5 × 10−9 M | [ |
| Bromate | CMK-3 (SBA-15/sucrose) | P2Mo18 | GCE/(OMC + PVA) film | Mediated EC | A | 2.77 × 10−6–4 × 10−3 M | 9.22 × 10−7 M | [ |
| Captopril | OMC | CuHCF | GCE/OMC/CuHCF film | Direct det./EC | CV | 1.0 × 10−5–2.7 × 10−3 M | 1.2 × 10−6 M | [ |
| Catechol | N-doped OMC | N (nitrogen) | GCE/OMC film | Direct det./EC | DPV | 6 × 10−6–7 × 10−5 M | 0.9 × 10−6 M | [ |
| CdII | OMC | Sn-Pb NPs | GCE/OMC film | Acc.—det. | SWASV | 1–140 µg∙L−1 | 0.36 µg∙L−1 | [ |
| Ciprofloxacin | CMK-3 (SBA-15/sucrose) | CTAB (0.1 mM) | CPE + OMC (15%) | Acc. (4 min)—det. | LS-AdsSV | 5.0 × 10−9–2.0 × 10−5 M | 1.5 × 10−9 M | [ |
| Citrinin | CMK-3 (SBA-15/sucrose) | Gold NPs | AuE/OMC/MIP film | Direct det. | EQCM | 6.0 × 10−9–2.0 × 10−7 M | 1.8 × 10−9 M | [ |
| Cl− | CIM carbon | IL-PVC | OMC-IL-PVC membrane | Direct detection | P | 3.16 × 10−4–1 × 10−1 M | - | [ |
| Dimetridazole | CMK-3 (SBA-15/sucrose) | Gold NPs/MIP | GCE/GO/OMC/MIP film | Acc. (3 min)—det. | DPV | 2.0 × 10−9–2.5 × 10−7 M | 5.0 × 10−10 M | [ |
| Large mesoporous C | CoHCF | GCE/OMC film | Mediated EC | A | 1.0 × 10−7–1.9 × 10−3 M | 1.7 × 10−8 M | [ | |
| Dopamine | CMK-3 (SBA-15/sucrose) | unmodified | GCE/OMC film | Direct det. | DPV | 5 × 10−8–1.0 × 10−6 M | 4.5 × 10−9 M | [ |
| Dopamine | OMC | Ru(bpy)32+ | GCE/(OMC + Nafion) film | Direct det. | ECL | 5.0 × 10−9–5.0 × 10−4 M | 1.7 × 10−9 M | [ |
| Dopamine, | CMK-3 (SBA-15/sucrose) | -COOH, IL | OMC + IL mixture rubbed onto GCE | Acc.—det. | DPV | 1 × 10−7–5 × 10−4 M | 4.1 × 10−9 M | [ |
| Estradiol | CMK-3 (SBA-15/sucrose) | Poly( | GCE/(OMC + | Mediated EC | SWV | 1.0 × 10−8–2.0 × 10−6 M | 5.0 × 10−9 M | [ |
| Ethanol, | CMK-3 (SBA-15/sucrose) | Ni(OH)2 NPs | GCE/(OMC + Nafion) film | Mediated EC | A | up to 8.0 × 10−2 M | 4.77 × 10−6 M | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | Platinum NPs | GCE/(OMC + Nafion) film | Supported EC | A | 5 × 10−6–7.5 × 10−3 M | 3 × 10−6 M | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | NiO | GCE/(OMC + Nafion) film | Supported EC | A | 2 × 10−6–1 × 10−3 M | 6.5 × 10−7 M | [ |
| Glucose | Onion-like OMC | PtPd NPs | GCE/(OMC + Nafion) film | Supported EC | A | 1.5 × 10−3–1.2 × 10−2 M | - | [ |
| Glucose | CMK-3 (SBA-15/Furfuryl alcohol) | CuO NPs | GCE/(OMC + Nafion) film | Supported EC | A | 1 × 10−5–1 × 10−3 M | - | [ |
| Glucose | OMC (colloidal SiO2/F127/phenolic resin) | CuO NPs | GCE/OMC film | Supported EC | A | 4 × 10−7–7.3 × 10−3 M | 1 × 10−7 M | [ |
| Glucose | Carbon aerogel (resorcinol/formaldehyde) | Iron/iron oxide | CPE + OMC | Supported EC | A | 1 × 10−3–5.0 × 10−2 M | - | [ |
| Glucose | IFMC | Palladium NPs | GCE/OMC/Nafion film | Supported EC | A | 1 × 10−3–5.5 × 10−2 M | 2 × 10−4 M | [ |
| Glucose | OMC | Co3O4 nanocrystals | GCE/(OMC + Nafion) film | Supported EC | A | 1 × 10−5–0.8 × 10−3 M | 1 × 10−6 M | [ |
| Glutathione | CMK-3 (SBA-15/sucrose) | Co oxide (Co3O4) | GCE/(OMC + Nafion) film | Mediated EC | A | 4 × 10−6–2.8 × 10−5 M | 1.4 × 10−10 M | [ |
| Guanine | CMK-3 (SBA-15/sucrose) | CePW | GCE/OMC film | Mediated EC | CV | 4 × 10−6–1.9 × 10−3 M | 5.7 × 10−9 M | [ |
| H+ (pH sensor) | OMC | RuO2 film | OMC-SPE | Direct detection | P | 1 × 10−10–1 × 10−4 M | - | [ |
| HgII | Mesoporous C nanofiber | BIM ligand | GCE/(OMC+BIM+Nafion) film | Acc. (15 min)—det. | DPASV | 5 × 10−9–5 × 10−7 M | 3 × 10−10 M | [ |
| Hydrazine | CMK-3 (SBA-15/sucrose) | PDDA—Pt NPs | GCE/(OMC + Nafion) film | Supported EC | A | 5 × 10−6–1.35 × 10−4 M | 1.7 × 10−7 M | [ |
| Hydrazine | CMK-3 (SBA-15/sucrose) | CeHCF | GCE/(OMC + Nafion) film | Mediated EC | A | 1 × 10−6–1.63 × 10−4 M | 1 × 10−7 M | [ |
| Hydrazine | OMC | CeO2 NPs | GCE/OMC/Nafion film | Supported EC | A | 4.0 × 10−8–1.92 × 10−4 M | 1.2 × 10−8 M | [ |
| Hydrazine | OMC | Curcumin | GCE/OMC film | Direct det./EC | A | 1.25 × 10−5–2.25 × 10−4 M | 3.9 × 10−7 M | [ |
| Hydrazine | CMK-1 (MCM-48/sucrose) | SDS—Pd NPs | GCE/(OMC + Nafion) film | Supported EC | A | 3 × 10−6–1 × 10−3 M | 1.16 × 10−6 M | [ |
| Hydrazine | CMK-1 (MCM-48/sucrose) | Platinum NPs | GCE/(OMC + Nafion) film | Supported EC | A | 1 × 10−5–8.4 × 10−4 M | 3.41 × 10−6 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Fe oxide (Fe3O4) | GCE/(OMC + Nafion) film | Mediated EC | A | 7 × 10−6–4 × 10−3 M | 3.6 × 10−8 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Cu2S | GCE/(OMC + Nafion) film | Mediated EC | A | 1 × 10−6–3.03 × 10−3 M | 2 × 10−7 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Gold NPs | GCE/OMC film | Supported EC | A | 2.0 × 10−6–3.92 × 10−3 M | 4.9 × 10−7 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Platinum NPs | GCE/OMC-PIL film | Supported EC | A | 1.0 × 10−7–3.2 × 10−3 M | 8 × 10−8 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Palladium NPs | GCE/(OMC + Nafion) film | Supported EC | A | 7.5 × 10−6–1.0 × 10−2 M | 1.0 × 10−6 M | [ |
| Hydrogen peroxide | LMC (CaCO3/sucrose) | Co(salen) | GCE/(OMC + Nafion) film | Mediated EC | A | 2.0 × 10−6–8.9 × 10−3 M | 8.5 × 10−7 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | MnO2 | GCE/(OMC + Nafion) film | Supported EC | A | 5 × 10−7–6 × 10−4 M | 7.8 × 10−8 M | [ |
| Hydrogen peroxide | OMC (SBA-15/glucose) | Silver NPs | GCE/OMC film | Supported EC | A | 0.1 × 10−6–4.1 × 10−5 M | 5.0 × 10−8 M | [ |
| Hydrogen peroxide | CMK-5 (SBA-15/furfuryl alcohol) | Fe-PTPY (grafted or adsorbed) | GCE/OMC film | Mediated EC | A | 1 × 10−5–1.3 × 10−2 M | 2 × 10−6 M | [ |
| Hydrogen peroxide | OMC | pFeMOF | GCE/(OMC + Nafion) film | Supported EC | A | 5 × 10−7–7.05 × 10−5 M | 4.5 × 10−7 M | [ |
| Hydrogen peroxide | OMC (colloidal SiO2/F127/phenolic resin) | Hemin | GCE/(OMC + Nafion + hemin) film | Direct det./EC | A | 2.0 × 10−6–2.5 × 10−4 M | 3 × 10−7 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Prussian Blue | GCE/OMC film | Mediated EC | A | 4 × 10−4–5.6 × 10−3 M | 1 × 10−6 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | Platinum NPs | GCE/(OMC + Nafion) film | Supported EC | A | 2 × 10−6–4.21 × 10−3 M | 1.2 × 10−6 M | [ |
| Hydrogen peroxide | Macroporous carbon | CuO nanoneedles | GCE/OMC film | Supported EC | A | 1.0 × 10−5–6.5 × 10−3 M | 2 × 10−7 M | [ |
| Hydrogen peroxide | Onion-like OMC | Palladium NPs | GCE/(OMC + Nafion) film | Supported EC | A | 1.0 × 10−7–6.1 × 10−3 M | 7.9 × 10−8 M | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | POMs/gold NPs | GCE/Au@POMs/OMC film | Supported EC | A | 1 × 10−6–2.0 × 10−5 M | 3.6 × 10−7 M | [ |
| Hydrogen peroxide | LMC (CaCO3/sucrose) | PDDA/gold NPs | GCE/OMC-PDDA-Ag- or Au-NPs/chitosan film | Supported EC | A | 2.0 × 10−5–9.62 × 10−3 M | 6.5 × 10−6 M | [ |
| Hydroquinone | N,S dual-doped OMC | N (nitrogen) and S (sulfur) | GCE/OMC film | Direct det./EC | DPV | 1 × 10−6–1.1 × 10−4 M | 5.6 × 10−8 M | [ |
| Iodate | OMC (MCM-41/sucrose) | Silver NPs | GCE/OMC film | Supported EC | A | 1.5 × 10−5–4.43 × 10−3 M | 3.01 × 10−6 M | [ |
| Luminol | CMK-3 (SBA-15/sucrose) | PANI | GCE/OMC/PANI film | Direct det. | ECL | 1.0 × 10−7–5.0 × 10−5 M | 8.8 × 10−10 M | [ |
| K+ | Macroporous carbon | K+ ionophore | Ni/OMC/membrane | Direct det. | P | 1.0 × 10−7–3.7 × 10−4 M | 10−6.2 M | [ |
| K+ | CIM carbon | K+ ionophore | Au/(OMC + PVC) film/valinomycine membrane | Direct det. | P | 1 × 10−5–1 × 10−1 M | 10−5.6 M | [ |
| K+ | Macroporous carbon | K+ ionophore | Ni/OMC/membrane | Direct det. | P | 10−6–10−3 M | 1.6 × 10−7 M | [ |
| Metolcarb | CMK-3 | Prussian Blue | GCE/OMC film | Acc. (5 min)— Mediated EC | LSV | 5.0 × 10−10–1.0 × 10−4 M | 9.3 × 10−11 M | [ |
| 2-mercaptoethanol | CMK-3 (SBA-15/sucrose) | DDAB/bi-CoPc | GCE/DDAB/OMC film | Mediated EC | A | 2.5 × 10−6–1.4 × 10−4 M | 6 × 10−7 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | C60 | GCE/OMC film | Direct det./EC | A | 1.0 × 10−7–9.0 × 10−4 M | 3 × 10−8 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Nile Blue | GCE/OMC film | Mediated EC | A | 5.0 × 10−5–1.25 × 10−3 M | 1.2 × 10−6 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Toluidine Blue O | GCE/(OMC + IL) film | Mediated EC | A | 1.0 × 10−6–1.0 × 10−3 M | 4 × 10−7 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Polythionine | GCE/OMC film | Mediated EC | A | 3.4 × 10−6–8.5 × 10−4 M | 5.1 × 10−8 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Poly(Azure B) | GCE/OMC film | Mediated EC | A | 3.0 × 10−6–1.0 × 10−3 M | 1.0 × 10−7 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Poly(neutral red) | GCE/OMC film | Mediated EC | A | up to 1.6 × 10−3 M | 1.5 × 10−7 M | [ |
| NADH | CMK-3 (SBA-15/sucrose) | Polycatechol | GCE/OMC film | Mediated EC | A | up to 2.5 × 10−4 M | 2 × 10−7 M | [ |
| Nitrobenzene | N-doped OMC (SBA-15/(NH4)2S2O8/aniline) | Ag NPs | GCE/(OMC + Nafion) film | Supported EC | DPV | 6.6 × 10−8–1.1 × 10−6 M | 6.6 × 10−9 M | [ |
| Ofloxacin | MCNs | MIP | GCE/MCNs@MIP | Acc.—det. | CV | 5 × 10−7–1 × 10−4 M | 8.0 × 10−8 M | [ |
| Omeprazole | OMC (fructose/F127) | MPTES | CPE + OMC (5%) | Acc. (60 s)—det. | DPV | 0.25 × 10−9–2.5 × 10−7 M | 0.04 × 10−9 M | [ |
| Oxygen (dissolved) | CMK-3 (SBA-15/sucrose) | TTF | GCE/(OMC + chitosan + Nafion) film | Direct det./EC | A | 7 × 10−6–1.93 × 10−4 M | 3.9 × 10−7 M | [ |
| PbII | Oxidized OMC (F127, resorcinol/formaldehyde) | Fe3O4 | Graphite rod/OMC film | Acc. (6 min)—det. | SWASV | 0.005–0.445 mg∙L−1 | 1.57 µg∙L−1 | [ |
| PbII | CMK-3 (SBA-15/sucrose) | Bismuth(III) | CPE + OMC | Acc. (150 s)—det. | SWASV | 1–70 µg∙L−1 | 0.08 µg∙L−1 | [ |
| PbII | HMCS | Bismuth oxide | GCE/(OMC + chitosan) film | Acc. (150 s)—det. | SWASV | 3 × 10−12–2.1 × 10−11 M | 1.7 × 10−12 M | [ |
| PbII | CMK-3 (SBA-15/sucrose) | PANI-MES | GCE/OMC/PANI-MES film | Acc. (150 s)—det. | DPASV | 1 × 10−9–1.2 × 10−7 M | 1.6 × 10−10 M | [ |
| Quercetin | OMC | IL-MoS2-Pd NPs | GCE/OMC film | Supported EC | LSV | 2.0 × 10−8–1.0 × 10−5 M | 8.0 × 10−9 M | [ |
| Ractopamine | OMC | Electrodeposited Au | GCE/OMC film | Supported EC | DPV | 3 × 10−8–7.5 × 10−5 M | 4.4 × 10−9 M | [ |
| Ractopamine | OMC | Electrodeposited Au NPs | SPCE/OMC/AuNPs/MIM film | Acc. (100 s)—det. | DPV | 5 × 10−11–1 × 10−9 M | 4.2 × 10−11 M | [ |
| Superoxide anion | N-doped HMCS (silica/resorcinol/formaldehyde) | N (nitrogen) | SPCE/OMC film | Direct det./EC | A | 2.0 × 10−5–4.8 × 10−4 M | 2.2 × 10−6 M | [ |
| Theophylline | LMC (CaCO3/sucrose) | SWCNT | GCE/(OMC-SWCNT + Nafion) film | Acc. (100 s)—det. | DPV | 3 × 10−7–3.8 × 10−5 M | 8 × 10−8 M | [ |
| Uric acid | CMK-3 (SBA-15/sucrose) | Ferrocene-COOH | GCE/(OMC + Nafion) film | Mediated EC | A | 6 × 10−5–3.9 × 10−4 M | 1.8 × 10−6 M | [ |
a Abbreviations: NADH, nicotinamide adenine dinucleotide (reduced form). b Abbreviations: CMK, carbon mesostructures at KAIST; SBA, Santa Barbara Amorphous; N-PCNPs, nitrogen-doped porous carbon nanopolyhedra; ZIF-8, zeolitic imidazolate framework-8; CIM carbon, colloid-imprinted mesoporous carbon; IFMC, ionic liquid derived fibrillated mesoporous carbon; LMC, large mesoporous carbon; MCNs, mesoporous carbon nanoparticles; HMCS, hollow mesoporous carbon spheres. c Abbreviations: Ni-Al LDH, nickel-aluminium layered double hydroxide; Ferrocene-COOH, ferrocene-carboxylic acid; NPs, nanoparticles; P2Mo18 , polyoxometalate; CuHCF, copper hexacyanoferrate; CTAB, cetyltrimethylammonium bromide; IL-PVC, ionic liquid poly(vinyl chloride); MIP, molecularly imprinted polymer; CoHCF, cobalt hexacyanoferrate; IL, ionic liquid; CePW, cerium(III) 12-tungstophosphoric acid; BIM, bis(indoyl)methane; PDDA, poly(diallylammonium chloride); CeHCF, cerium hexacyanoferrate; SDS, sodium dodecyl sulfate; Co(salen), [N,N’-bis(salicylaldehyde) ethylenediimino cobalt(III)]; Fe-PTPY, iron terpyridine complex; pFeMOF, porphyrinic iron metal-organic framework; POMs, polyoxometalates; BMIMPF6, ionic liquid of 1-octyl-3-methylimidazolium bromide; PANI, polyaniline; DDAB/bi-CoPc, binuclear cobalt phthalocyanine exchanged on a didodecyldimethylammonium bromide film; C60, fullerene; MIP, molecularly imprinted polymer; MPTES, mercaptopropyltriethoxysilane; TTF, tetrathiafulvalene; PANI-MES, 2-mercaptoethanesulfonate-tethered polyaniline; SWCNT, single walled carbon nanotube. d Abbreviations: GCE, glassy carbon electrode; OMC, ordered mesoporous carbon (general term to name the porous carbon material, even if modified, as detailed in the preceeding columns); LDH, layered double hydroxide; PVA, poly(vinyl alcohol); CuHCF, copper hexacyanoferrate; CPE, carbon paste electrode; AuE, gold electrode; IL-PVC membrane, ionic liquid poly(vinyl chloride) membrane; GO, graphene oxide; MIP, molecularly imprinted polymer; IL, ionic liquid; SPE, screen-printed electrode; BIM, bis(indoyl)methane; PIL, poly(ionic liquid); Au@POMs/OMC, gold nanoparticles and polyoxometalates decorated OMC; PDDA-Ag- or Au-NPs, silver or gold nanoparticles onto poly(diallyldimethylammonium chloride); PANI, polyaniline; PVC, poly(vinyl chloride); DDAB, didodecyldimethylammonium bromide; MCNs@MIP, molecularly imprinted polymer/mesoporous carbon nanoparticles composite; MES, mercaptoethanesulfonate; SPCE, screen-printed carbon electrode; MIM, molecular imprinted membrane; SWCNT, single walled carbon nanotube. e Abbreviations: EC, electrocatalysis; det., detection; acc., accumulation. f Abbreviations: A, amperometry; P, potentiometry; DPV, differential pulse voltammetry; SWV, square wave voltammetry; CV, cyclic voltammetry; SWASV, square wave anodic stripping voltammetry; LS-AdsSV, linear sweep adsorptive stripping voltammetry; EQCM, electrochemical quartz crystal microbalance; ECL, electrochemiluminescence; DPASV, differential pulse anodic stripping voltammetry; LSV, linear sweep voltammetry.
Figure 7(A) Cyclic voltammograms (CV) of (a) glassy carbon electrode (GCE) modified with silver nanoparticles (AgNPs) functionalized OMC (GCE/OMC/AgNPs), (b) GCE/OMC, and (c) bare GCE in 0.1 M phosphate buffer solution (pH 7) containing 0.1 mM H2O2; (d) CV of GCE/OMC/AgNPs in blank electrolyte. (B) CV of 0.025 mM H2O2 on GCE/OMC/AgNPs recorded at various scan rates (10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 180, 200, 220, 240 mV∙s−1) in the same medium as in (A) with corresponding plot of peak current versus square root of scan rate in inset. (C) Amperometric responses of (a) GCE/OMC/AgNPs and (b) GCE/OMC at −0.2 V to successive addition of H2O2 (0.1–5 µM); plot of current vs. H2O2 concentration (inset 1) and current-time curve for GCE/OMC/AgNPs recorded at bare glassy carbon electrode (GCE) and graphitized mesoporous carbon (GMC) modified exposed to 0.01 mM of H2O2 and 0.1 mM of ascorbic acid (AA), dopamine (DP), uric acid (UA), acetaminophen (AP), epinephrine (EP), l-cysteine (L-C) and l-tyrosine (L-T) and finally 0.01 mM of H2O2 (inset 2) (reproduced from [148]).
Figure 8(A) Typical j–t curves obtained at glassy carbon electrodes (GCE) modified with Co3O4 nanocrystals (GCE/Co3O4 NPs), or with Co3O4 nanocrystals-decorated reduced graphene oxide (GCE/Co3O4-RGO), macroporous carbon (GCE/Co3O4-MPC), and ordered mesoporous carbon (GCE/Co3O4-OMC) on the successive injection of glucose in 0.1 M NaOH solution at 0.55 V vs. Ag/AgCl, on which the concentration denoted the final glucose concentration; the corresponding modifiers are illustrated on the left. (B) The j–t curve of GCE/Co3O4-OMC with the successive addition of 1 mM glucose, 0.1 mM interference substances, and 1 mM glucose at +0.55 V vs. Ag/AgCl (reproduced from [164]).
Figure 9Preconcentration electroanalysis of mercuric ions at a glassy carbon electrode (GCE) modified with bis(indolyl)methane (BIM) on ordered mesoporous carbon nanofibers (OMC) and Nafion (GCE/BIM/OMC/Nafion); accumulation at open-circuit, electrochemical reduction and detection by differential pulse anodic stripping voltammetry (DPASV). (A) DPASV curves obtained at GCE/BIM/OMC/Nafion with open-circuit accumulation in 0.1 M phosphate buffer solution (pH 6) containing 5.0–500 nM Hg2+; Inset showed the corresponding calibration plot; amplitude of 0.05 V; pulse width of 0.05 s; pulse period of 0.2 s; quiet time of 2 s. (B) DPASV curves obtained at (a) GCE/BIM/OMC/Nafion and (b) GCE/OMC/Nafion in the presence of 1.0 µM Hg2+ + 10.0 µM Pb2+ + 10.0 µM Cu2+ + 10.0 µM Cd2+; solid lines: 15 min open-circuit accumulation; dash lines: electro-accumulation at −1.2 V for 15 min; other conditions as in part A (reproduced from [127]).
Electrochemical biosensors based on electrodes prepared from templated ordered porous carbon materials.
| Analyte | Porous Materials | Immobilized | Electrode Configuration d | Analytical Performance | Stability | Reference | ||
|---|---|---|---|---|---|---|---|---|
| Type (Template, C Source) a | Modifier b | Biomolecule(s) c | Concentration Range | Det. Limit | ||||
| Aflatoxin B1 | MCNs | Thionine | AFB1 antibody | GCE/OMC-Thi/GluA/AFB1 + BSA | 10–2 × 104 ng∙L−1 | 3 ng∙L−1 | 20 days (100%) | [ |
| Aflatoxin B1 | MCF | Ag NPs | AFB1 antibody | GCE/OMC/Ag/luminol/AFB1 + BSA | 0.1–5 × 104 ng∙L−1 | 50 pg∙L−1 | - | [ |
| 3-Bromobiphenyl | CMK-3 (SBA-15/sucrose) | PB-PD | Ab2 antibody | ITO/OMC-PB-PD/multi-HRP-DHCNTs-Ab2 | 5 × 10−12–2 × 10−9 M | 2.25 × 10−12 M | 7 days (96%) | [ |
| Calmodulin (CaM) | HMPC | PAupc | Ab1 antibody + HRP | GCE/(OMC-chitosan)/Ab1 + BSA + HRP-PAupc-Ab1 | 5–105 ng∙L−1 | 1.5 ng∙L−1 | - | [ |
| Cancer biomarker (EGFR) | CMK-3 (SBA-15/sucrose) | Poly(AC | EGFR antigenC | AuE/(OMC + poly(AC | 10–5 × 104 ng∙L−1 | 3 ng∙L−1 | - | [ |
| Catechol | CMK-3 (SBA-15/sucrose) | Copper | LAC | Au/(OMC-Cu/LAC + chitosan) | 6.7 × 10−7–1.57 × 10−5 M | 6.7 × 10−7 M | 30 days (95%) | [ |
| Catechol | GMC (SiO2 nanospheres/PS) | Co3O4 nanorods | TYR | GCE/OMC-TYR-Co3O4/chitosan | 5.0 × 10−8–1.3 × 10−5 M | 2.5 × 10−8 M | 2 months (86%) | [ |
| Carcinoembryonic antigen | MCF | Au NPs | Ab2 antibody | GCE/(GO/chitosan/BSA) (OMC/Au/Ab2) | 0.05–103 ng∙L−1 | 24 pg∙L−1 | 15 days (92%) | [ |
| Chlorpyrifos | OMC | Fc@MWCNTs-CS | Aptamer | GCE/(OMC-chitosan)/Fc@MWCNTs-CS/(Apt + BSA) | 5–105 µg∙L−1 | 0.33 µg∙L−1 | 2 weeks (96%) | [ |
| Ethanol | CMK-3 (SBA-15/sucrose) | Meldola’s Blue | ADH | GCE/OMC-MB/(ADH + BSA + GluA) | up to 6 × 10−3 M | 1.9 × 10−5 M | 15 days (22%) | [ |
| Ethanol | GMC | Meldola’s Blue | ADH | SPE/(OMC + chitosan + MB + ADH) | 5 × 10−4–1.5 × 10−3 M | 8.0 × 10−5 M | 40 days (91%) | [ |
| Ethanol | CMK-3 (SBA-15/sucrose) | - | ADH | GCE/OMC/(enzyme + BSA)/GluA/Nafion | 3.0 × 10−4–1.3 × 10−2 M | 1.0 × 10−4 M | 1 month (91%) | [ |
| Glucose | MCF (MSU-F/furfurylalcohol) | - | GOD | GCE/(OMC-GOD + Nafion) | up to 7 × 10−3 M | 7 × 10−5 M | 20 days | [ |
| Glucose | 2D-OMC (SBA-15/sucrose) 3D-OMC (FDU-5/sucrose) | - | GOD | GCE/(OMC-GOD + Nafion) | up to 7.94 × 10−3 M | 1.0 × 10−5 M | 45 days (86%) | [ |
| Glucose | CMK-3 (SBA-15/furfuryl alcohol) | Iron oxide | GOD | Pt/(OMC-Fe3O4 + GOD)/Nafion | 2 × 10−4–1.0 × 10−2 M | 8 × 10−5 M | 1 week (90%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | Pt NPs | GOD | GCE/(OMC-Pt + gelatin + GOD + GluA) | 4 × 10−5–1.22 × 10−2 M | 1 × 10−6 M | 30 days (95%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | Pt NPs | GOD | GCE/(OMC-Pt + Nafion) imp. GOD | up to 7.94 × 10−3 M | 1 × 10−6 M | 27 days (31%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | Pt NPs | GOD | Au/OMC-Pt/PPy-GOD | 5 × 10−5–3.7 × 10−3 M | 5 × 10−5 M | 15 days (50%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | Au NPs | GOD | GCE/OMC-Au/GOD | 5.0 × 10−5–2.2 × 10−2 M | - | 30 days (88%) | [ |
| Glucose | FDU-15 | - | GOD | GCE/(OMC-GOD + Nafion) | 1 × 10−4–1 × 10−3 M | 9 × 10−5 M | - | [ |
| Glucose | FDU-15 or FDU-16 (F127-resol) | - | GOD | SPE (OMC + PHBMA)/GOD | 5–100 mg∙L−1 | - | - | [ |
| Glucose | ACF | - | GOD | SPE/OMC/GOD | up to 20 mM | - | 5 days (68%) | [ |
| Glucose | MSCF | - | GOD | GCE/(MSCF/GOD + Nafion) | 5.0 × 10−5–5.0 × 10−3 M | 3.4 × 10−5 M | 2 weeks (94%) | [ |
| Glucose | IFMC | Pd NPs | GOD | GCE/(Pd@IFMC/GOD/Nafion) | 5 × 10−4–10−2 M | 1.9 × 10−4 M | 2 weeks (91%) | [ |
| Glucose | LMC (CaCO3/sucrose) | Co(salen) | GOD | GCE/OMC/Co(salen)/GOD | 5 × 10−4–1.3 × 10−2 M | 2 × 10−4 M | 10 days (92%) | [ |
| Glucose | MCF (MSU-F/furfuryl alcohol) | Fe3O4 NPs | GOD | CPE (OMC-Fe3O4 + GOD) | 5 × 10−4–1.0 × 10−2 M | 2 × 10−4 M | 2 months (90%) | [ |
| Glucose | BGMC (KIT-6/sucrose) | - | GOD | GCE/(OMC/GOD + Nafion) | up to 7.49 × 10−3 M | 1.0 × 10−5 M | 30 days (95%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | - | GOD | CPE (OMC + GOD) | up to 15 × 10−3 M | 7.2 × 10−5 M | - | [ |
| Glucose | OMC | - | GOD | µCPE (OMC + GOD + IL) | 1 × 10−5–8 × 10−5 M | - | 3 weeks (93%) | [ |
| Glucose | MC film (SiO2 nanospheres/SU-8 resin) | - | GOD | Continuous OMC film on silicon wafer + GOD | 5 × 10−4–5 × 10−3 M | - | - | [ |
| Glucose | OMC | AP-TCT | GOD | GCE/OMC film + grafted GOD | 1 × 10−3–1 × 10−2 M | 3.8 × 10−5 M | 1 month (94%) | [ |
| Glucose | MCF (MSU-F/furfuryl alcohol) | - | POx | GCE/(OMC + Nafion + POx) | up to 1 × 10−3 M | - | 20 days | [ |
| Glucose | HPGC (TEOS-F127- phenol-formalin) | PDA-Au NPs | GOD | HPGC membrane/PDA-Au NPs/GOD | 1 × 10−11–1.2 × 10−9 M | 4.8 × 10−12 M | 1 week (91%) | [ |
| Glucose | CMK-3 (SBA-15/sucrose) | NiFe2 NPs | GOD | GCE/(NiFe2-OMC + Nafion)/(GOD + BSA)/Nafion | 4.86 × 10−5–1.25 × 10−2 M | 2.7 × 10−6 M | 2 weeks (93%) | [ |
| Glucose | CNPs | FcMeOH | GOD | GCE/CNP-FcMeOH/GOD | up to 6.0 × 10−2 M | - | - | [ |
| Glucose | CMM | Pt NPs/ | GOD | GCE/Pt30%/PDDA-OMC/enzyme/Nafion | 5 × 10−7–5 × 10−5 M | 2.5 × 10−6 M | 2 weeks (88%) | [ |
| Glyphosate | CMK-3 (SBA-15/sucrose) | ZnS QDs | HRP | GCE/(OMC + chitosan)/ZnS QDs/HRP | 1 × 10−10–1 × 10−2 M | - | - | [ |
| HgII | OMC | Au NPs | DNA | GCE/PANI/AuNPs/ssDNA | 1 × 10−14–1 × 10−6 M | 6 × 10−16 M | 1 month (85%) | [ |
| Hydrogen Peroxide | OMC (SBA-15/glucose) | PVA | Hb | GCE/(OMC + PVA)/Hb | 4 × 10−7–8.75 × 10−5 M | 5 × 10−7 M | 2 weeks (95%) | [ |
| Hydrogen peroxide | CMK-3 (SBA-15/sucrose) | -COOH | Hb | GCE/{Chitosan/OMC-Hb}n | 1.2 × 10−6–5.7 × 10−5 M | 6 × 10−7 M | 30 days | [ |
| Hydrogen peroxide | GMC-6 (SiO2 pellets/PS) | - | Hb | GCE/(OMC-Hb + Nafion) | 1 × 10−6–1.84 × 10−4 M | 1 × 10−7 M | 16 days (97%) | [ |
| Hydrogen peroxide | GMC-380 | - | Hb | GCE/(OMC-Hb + Nafion) | 1 × 10−6–2.67 × 10−4 M | 1 × 10−7 M | 21 days (90%) | [ |
| Hydrogen peroxide | GMC monolith (SiO2 NPs/resorcinol-Fe/formaldehyde) | - | Hb | GCE/(OMC monolith fragments + DDAB + Hb) | 1 × 10−7–6.0 × 10−5 M | 1 × 10−7 M | 1 week (95%) | [ |
| Hydrogen peroxide | Macroporous carbon | -COOH | Cyt | OMC-Cyt | 2.0 × 10−5–2.4 × 10−4 M | 1.46 × 10−5 M | 1 month (86%) | [ |
| Hydrogen peroxide | Macroporous carbon | -COOH | Hb | GCE/OMC-Hb/Nafion | 1.0 × 10−5–8.0 × 10−5 M | - | weeks | [ |
| Hydrogen peroxide | FDU-15 | - | Hb | GCE/OMC film imp. Hb | 2 × 10−6–3 × 10−4 M | 8 × 10−7 M | 30 days (90%) | [ |
| Hydrogen Peroxide | OMCN (F127-resol) | - | Cyt c | ITO/(PDDA/OMC)n/Cyt c | 5 × 10−6–1.5 × 10−3 M | 1 × 10−6 M | 20 days (82%) | [ |
| Hydrogen Peroxide | Carbon aerogel (resorcinol/formaldehyde) | Ni | Mb | CPE + OMC | 5.0 × 10−6–9.75 × 10−4 M | 1.68 × 10−6 M | 2 weeks (>95%) | [ |
| Hydrogen Peroxide | MCF | - | Mb | GCE/OMC-grafted Mb | 3.5 × 10−6–2.45 × 10−4 M | 1.2 × 10−6 M | 20 days (95%) | [ |
| Hydrogen Peroxide | FDU-15 (F127-resol) | Pt NPs | Hb | GCE/PDDA/OMC-Pt NPs/Hb/Nafion | 2 × 10−6–6 × 10−2 M | 1.0 × 10−6 M | 20 days (96%) | [ |
| Hydrogen peroxide | OMC | - | Hb | MCCE (OMC + Hb) | 1 × 10−6–2.2 × 10−4 M | 4 × 10−7 M | 2 weeks (95%) | [ |
| Hydrogen Peroxide | OMC (SBA-15/furfuryl alcohol) | Fe3O4 | HRP | GCE/(OMC-Fe3O4 + HRP) | 2.4 × 10−7–7.2 × 10−4 M | 1.04 × 10−7 M | 2 weeks (86%) | [ |
| Hydrogen peroxide | 3D-KSC | MOFs | MP-11 | OMC-enzyme composite | 3.9 × 10−7–1.7 × 10−3 M | 1.27 × 10−7 M | 30 days (89%) | [ |
| Hydroquinone | OMC | Au NPs | TYR | GCE/OMC-Au NPs/ | 4 × 10−7–8 × 10−5 M | 5 × 10−8 M | 1 month (85%) | [ |
| Hydroquinone | OMC | Au NPs | TYR | GCE/(Au NPs + | 1 × 10−7–1.1 × 10−4 M | - | - | [ |
| Norepinephrine | OMC (TEOS-F127-resol) | - | PNMT | SPE (OMC + PHBMA) | 1-500 ng∙L−1 | 0.1 ng∙L−1 | - | [ |
| Organophosphorus pesticides | OMC | Fe3O4 | AChE | SPE/(OMC + Fe3O4 + chitosan)/AChE | 1-600 µg∙L−1 | 0.05 µg∙L−1 | - | [ |
| Paraoxon | OMC | - | OPH | GCE/(CB + OMC)/(OPH + Nafion) | 2 × 10−7–8 × 10−6 M | 1.2 × 10−7 M | - | [ |
| Paraoxon | CMK-3 (SBA-15/sucrose) | - | OPH | GCE/(OMC + Nafion)/bacteria-OPH | 5 × 10−8–2.5 × 10−5 M | 9 × 10−9 M | 1 month (70%) | [ |
| PbII | OMC | Au NPs | DNAzyme | GCE/ | 5 × 10−10–5 × 10−5 M | 2 × 10−10 M | 1 month (87%) | [ |
| Penicillin binding protein 2 a | GMC | Au NPs | Ab1 antibody | AuE/PAMAM/(OMC-Au NPs)/Protein A/Ab1/BSA | 25–6400 ng∙L−1 | 0.65 ng∙L−1 | 21 days (91%) | [ |
| Phenol | GMC | AA-IL | TYR | GCE/(OMC + AA-IL + TYR + chitosan) | 1 × 10−7–1.0 × 10−5 M | 2.0 × 10−8 M | 21 days (90%) | [ |
| Prostate-specific antigen | GMC | Au NPs | PSA aptamer | PGE/(OMC-Au NPs + chitosan) /BSA/PSA aptamer | 0.25–200 µg∙L−1 | 0.25 µg∙L−1 | 30 days (93%) | [ |
| Prostate-specific antigen | CMK-3 (SBA-15/sucrose) | Pd-SnO2 & Au NPs | Ab1 & Ab2 antigens, HRP | GCE/(Pd-SnO2-Au NPs + Ab1) + OMC/Au NPs-MB-Ab2-HRP | 0.01–100 µg∙L−1 | 3 ng∙L−1 | 15 days (96%) | [ |
| Tyramine | CMK-3 (SBA-15/sucrose) | - | TYR | GE/(OMC-TYR + PDDA + TiO2)/Nafion | 6 × 10−6–1.3 × 10−4 M | 1.5 × 10−6 M | 7 days | [ |
a Abbreviations: MCNs, mesoporous carbon nanospheres; MCF, mesoporous carbon foam; CMK, carbon mesostructures at KAIST; SBA, Santa Barbara Amorphous; HMPC, honeycomb-like mesoporous carbon; GMC, graphitized mesoporous carbon; PS, polystyrene; OMC, ordered mesoporous carbon; FDU, Fudan University (in Shanghai Materials); F127, F-127 block copolymer; ACF, activated carbon fibers obtained from carbonization of electrospinned polyaniline; MSCF, mesocellular silica-carbon nanocomposite foam; IFMC, ionic liquid derived fibrillated mesoporous carbon; LMC, large mesoporous carbon; BGMC, bicontinuous gyroidal mesoporous carbon; HPGC, hierarchically porous partially graphitic carbon; CNPs, mesoporous carbon nanoparticles; CMM, carbon mesoporous material; MCWC, mesoporous carbon/whisker-like carbon; OMCN, ordered mesoporous carbon nanospheres. b Abbreviations: NPs, nanoparticles; PB, Prussian Blue; PD, polydopamine; PAupc, poly(acrylic acid)-functionalized Au popcorn; Poly(AC-co-MDHLA), poly-acrylamide-co- methacrylate of dihydrolipoic acid; Fc@MWCNTs-CS, ferrocene functionalized chitosan on multiwalled carbon nanotubes; Co(salen), cobalt(II) Schiff base; AP-TCT, aminophenyl-2,4,6-trichloro-1,3,5-triazine; PDA, polydopamine; FcMeOH, ferrocene methanol; MB, methylene Blue; PDDA, poly(diallyl-dimethyl-ammonium chloride); QDs, quantum dots; PVA, poly(vinyl alcohol); Ppy, polypyrrole; MOFs, metal-organic frameworks; AA-IL, amino acid ionic liquid. c Abbreviations: HRP, horseradish peroxidase; EGFR, epidermal growth factor receptor; LAC, laccase; TYR, tyrosinase; ADH, alcohol dehydrogenase; GOD, glucose oxidase; POx, pyranose oxidase; LOD, lactate oxidase; DNA, desoxyribonucleic acid; Hb, Hemoglobin; Cyt c, Cytochrome c; Mb, Myoglobin; MP-11, microperoxidase-11; PNMT, phenylethanolamine N-methyl transferase; AChE, acetylcholinesterase; OPH, organophosphorus hydrolase; DNAzyme, deoxyribozyme; PSA, prostate-specific antigen. d Abbreviations: Acronyms used for biomolecules are found on the left column beside this one; GCE, glassy carbon electrode; OMC, ordered mesoporous carbon; Thi, thionine; GluA, glutaraldehyde; BSA, bovin serum albumin; ITO, indium-tin oxide; PB, Prussian Blue; PD, polydopamine; multi-HRP-DHCNTs-Ab2, multi-horseradish peroxidase-double helix carbon nanotubes-secondary antibody; HRP-PAupc-Ab1, horseradish peroxidase and Ab1 antigen covalently bound to poly(acrylic acid)-functionalized Au popcorn; AuE, gold electrode; Poly(AC-co-MDHLA), poly-acrylamide-co-methacrylate of dihydrolipoic acid; anti-EGFR, antigen of epidermal growth factor receptor; AMS, amino-functionalized mesoporous silica; Fc@MWCNTs-CS, ferrocene functionalized chitosan on multiwalled carbon nanotubes; MB, methylene blue; PPy-GOD, electrogenerated polypyrrole in the presence of glucose oxidase; SPE, screen-printed electrode; PHBMA, poly(tert-butyl methacrylate); MSCF, mesocellular silica-carbon nanocomposite foam; Pd@IFMC, nanohybrid material made of Pd nanoparticles decorated ionic liquid derived fibrillated mesoporous carbon; Co(salen), cobalt(II) Schiff base; µCPE, micro carbon paste electrode (formed in the microcavity of a Pt cavity ultramicroelectrode); HPGC membrane/PDA, hierarchically porous partially graphitic carbon membrane covered with polydopamine; CNP, carbon nanoparticle; PDDA, poly(diallyl-dimethyl-ammonium chloride); QDs, quantum dots; PANI, polyanilline; ssDNA, single strand DNA; PVA, poly(vinyl alcohol); DDAB, didodecyldimethylammonium bromide; (PDDA/OMC)n, n bilayers of poly(diallyl-dimethyl-ammonium chloride) and ordered mesoporous carbon particles; CPE, carbon paste electrode; MCCE, mesoporous carbon ceramic electrode; CB, carbon black; PAMAM, polyamidoamine; AA-IL, amino acid ionic liquid; PGE, pyrolytic graphite electrode; GE, graphite electrode.
Figure 10(A) Schematic illustration of a tyrosinase (TYR) OMC-based biosensor (TYR/TiO2/CMK-3/PDDA/Nafion, with PDDA = poly(diallyl-dimethyl-ammonium chloride)). (B) Corresponding calibration curve for catechol and comparison to a similar system based on carbon nanotubes (reproduced from [246]).
Figure 11(A) Schematic illustration of an alcohol dehydrogenase (ADH)-based biosensor constructed from ADH/NAD+/Meldola’s blue (MDB)/graphitized mesoporous carbon (GMC)/chitosan (CS-film) nanobiocomposite on a screen-printed electrode (SPE, shown on the photograph). (B) Typical amperometric response upon successive addition of NADH (10, 20 and 50 µM) in a stirred Tris-HCl buffer solution (0.1 M, pH 8.0, 300 rpm) at a working potential of −0.15 V, and the corresponding calibration curve (inset). (C) Amperometric responses upon successive addition of 15 µM NADH, 500 µM uric acid (UA), 100 µM H2O2, 500 µM dopamine (DA), 100 µM NaCl, 100 µM KCl, 100 µM CaCl2, 100 µM MgCl2 and 500 µM ascorbic acid (AA), with operational potentials of −0.1 V and −0.15 V in the same conditions as in B (reproduced from [212]).
Figure 12Assembly and detection mechanism of an OMC-DNA-based biosensor for mercury ions (SPAN, self-doped polyaniline; MCH, 6-mercaptohexanol; AQDS, anthraquinone-2,6-disulfonate) (reproduced from [257]).
Figure 13(A) Schematic illustration of competitive-type immunosensing strategy, based on target-induced displacement reaction between thionine-decorated mesoporous carbon nanospheres bearing the antibody (pAb-MSC-Thi) and an Nafion-modified glassy carbon electrode (Nafion-GCE) for the electrochemical detection of aflatoxin B1 (AFB1). (B) Differential pulse voltammograms recorded for the immunoassay toward increasing AFB1 concentrations (reproduced from [247]).
Figure 14Schematic representation of an electrochemical immunosensor for calmodulin (CaM) based on enhanced biocatalyzed precipitation adopting a dual-layered enzyme strategy using a glassy carbon electrode (GCE) successively covered with mesoporous carbon, gold nanoparticles (AuNPs), Ab1 antibody, bovine serum albumin (BSA), the CaM target, horseradish peroxidase and Ab1 antigen covalently bound to poly(acrylic acid)-functionalized Au popcorn (HRP-PAupc-Ab1) and horseradish peroxidase-secondary antobody (HRP-Ab2) (reproduced from [250]).
Figure 15(A) Schematic diagram for the stepwise assembly of an electrochemical immunosensor for prostate-specific antigen (PSA) operating in the signal amplification strategy using a glassy carbon electrode (GCE) successively covered with gold nanoparticles (AuNPs) deposited onto flower-like SnO2 anchored with palladium NPs (Pd@SnO2), Ab1 antibody, ovalbumin (OVA), the PSA target, and the bioconjugate in the form of CMK-3 with AuNPs, horseradish peroxidase (HRP) and methylene blue (MB) (reproduced from [256]). (B) Fabrication procedure for penicillin binding protein 2 a (PbP2a) immunosensor based on gold electrode covered with polyamidoamine (PAMAM), AuNPs decorated graphitized mesoporous carbon (GMC), protein A and Ab1 antibody, the antigen (Ag) and the nanocarriers made of hollow gold nanospheres (HGNPs) incubated with the second antibody (Ab2) and doxorubicin (Dox)(reproduced from [254]).